14 hrs ago
Investor's Business Daily
Merck, J&J, Baxter Provide Healthy Dividend Stream
But earnings climbed 1% to 85 cents a share for its third straight quarter of gains.
17 hrs ago
The News Tribune
J&J withdraws fibroid treatment device from market
In April, J&J suspended sales of the devices, known as laparoscopic power morcellators, after the Food and Drug Administration discouraged doctors from using them.
17 hrs ago
J&J to call for voluntary return of morcellators
Johnson & Johnson, which already suspended sales of a surgical tool that has been blamed for spreading a dangerous cancer in women, now plans to tell doctors world-wide to return any devices currently on shelves.
17 hrs ago
J&J seeks return of device seen as possibly raising cancer risk
Johnson & Johnson said on Wednesday it plans to ask doctors to return its power morcellators, a controversial surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids.
19 hrs ago
What happens when suppliers grade customers with Two-Way Scorecards?
That's around the time leading brands began to look at outsourcing as a strategic activity as opposed to a tactical make-pack-ship kind of business.
23 hrs ago
This Food Giant Should Be Avoided
Things have been looking better as the economy has been recovering. There are good numbers coming in from the housing sector as well as retail.
#SeeTheRealMe: We're All For Teen-powerment
As teens, you get insecure about a lot of things: pimples, your period, having people judge you, dealing with rejection, and the list goes on.
Tue Jul 29, 2014
Why Is Donald Hot For The Avon Lady?
Yacktman has a stellar long-term record. His flagship fund has out performed 99% of its peers over the last 15 years.
Inside the deal: Price disclosed for Philly Swirl
It always amazes me when two companies doing a deal don't disclose financial terms - especially when one of those companies is publicly traded.
Mon Jul 28, 2014
J & J Snack Foods Reports Third Quarter Sales and Earnings
We had particular strong sales growth in our food service soft pretzel category led by our newer products such as pretzel rolls and sticks.
J&J Snack Foods Corp - 10-Q - Management's Discussion and Analysis of ...
Liquidity and Capital Resources Our current cash and cash equivalents balances and cash expected to be provided by future operations are our primary sources of liquidity.
Sat Jul 26, 2014
Walter Joppy of J&J it Services support children in needWalter Joppy...
Walter Joppy of J&J IT Services support children in need Walter Joppy of J&J IT Services was this year's CASAblanca honoree Check out this story on mycentraljersey.com: http://mycj.co/1mPHEK7 Photo from left: Deb Cummins , Kelly Spillman , Lori Ross , Walter Joppy , Janet Wesselmann , and Tracey Heisler are shown at the recent 6th annual CASAblanca ... (more)
Fri Jul 25, 2014
Europe backs new leukaemia drugs from J&J and Gilead
Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.
Thu Jul 24, 2014
The Motley Fool
Why Organovo Holdings Inc Stock Bulked Up Today
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Organovo jumps 19% to $9.13 following agreement with J&J unit
Organovo enters 3D bio-printed tissue agreement with J&J unit Organovo announced that it has entered into an agreement with Janssen Research and Development, a pharmaceutical company of Johnson & Johnson , to evaluate the use of 3D bio-printed tissue in a drug discovery setting, outside of the company's work in 3D liver tissue for toxicity testing.
Wed Jul 23, 2014
3 Dividend Stocks For Retirement
As the US economy continues to post evidence of recovery, the Federal Reserve has more options available in defining its monetary policy strategies.
Tue Jul 22, 2014
The Motley Fool
Do This Drug's Sales Make J&J a Hepatitis C Powerhouse?
So why, you may ask, did the shares tank by 2%? As so often happens in the financial universe, I believe the reaction had more to do with perception than reality.
The Motley Fool
Tuesday's Top Health Care Stocks: Herbalife, Exact Sciences, AstraZeneca, J&J
During an interview on "Bottom Line" yesterday, Ackman announced that he would show how Herbalife's Nutrition Clubs were equivalent to Enron's fake trading rooms.
Mon Jul 21, 2014
Heartbeats: Public campaign underway for Saint Peter'sHeartbeats:...
Heartbeats: Public campaign underway for Saint Peter's Health news from New Brunswick, Bernards, Branchburg, Woodbridge, Central Jersey Check out this story on mycentraljersey.com: http://mycj.co/1mydYkp The new and expanded Pediatric Emergency Department at Saint Peter's University Hospital in New Brunswick was completed in the spring of 2013 and ... (more)
J&J buying back $5 billion worth of its shares
Johnson & Johnson, the world's biggest maker of health care products, plans to buy back up to $5 billion of the company's common stock.